Digital Consults to Enhance Heart Failure Treatment: The ADMINISTER Trial
Cardiology Update
AUGUST 4, 2024
Despite proven benefits in reducing morbidity and mortality, many heart failure (HF) patients do not receive optimal guideline-directed medical therapy (GDMT). This includes beta-blockers, ACE inhibitors, ARBs, ARNIs, MRAs, and SGLT2 inhibitors. ESC Heart Failure 2024; 11 : 560–569.
Let's personalize your content